147 related articles for article (PubMed ID: 35512420)
1. Design, synthesis and biological activity evaluation of a series of bardoxolone methyl prodrugs.
Liu L; Pan X; Xie F; Xu X; Xiao D; Xiao J; Zhou X
Bioorg Chem; 2022 Jul; 124():105831. PubMed ID: 35512420
[TBL] [Abstract][Full Text] [Related]
2. Novel Derivative of Bardoxolone Methyl Improves Safety for the Treatment of Diabetic Nephropathy.
Huang Z; Mou Y; Xu X; Zhao D; Lai Y; Xu Y; Chen C; Li P; Peng S; Tian J; Zhang Y
J Med Chem; 2017 Nov; 60(21):8847-8857. PubMed ID: 28994286
[TBL] [Abstract][Full Text] [Related]
3. A Point Mutation at C151 of
Gatbonton-Schwager T; Yagishita Y; Joshi T; Wakabayashi N; Srinivasan H; Suzuki T; Yamamoto M; Kensler TW
Mol Pharmacol; 2023 Aug; 104(2):51-61. PubMed ID: 37188495
[TBL] [Abstract][Full Text] [Related]
4. Identification and quantification of the basal and inducible Nrf2-dependent proteomes in mouse liver: biochemical, pharmacological and toxicological implications.
Walsh J; Jenkins RE; Wong M; Olayanju A; Powell H; Copple I; O'Neill PM; Goldring CE; Kitteringham NR; Park BK
J Proteomics; 2014 Aug; 108(100):171-87. PubMed ID: 24859727
[TBL] [Abstract][Full Text] [Related]
5. Bardoxolone methyl (CDDO-Me) as a therapeutic agent: an update on its pharmacokinetic and pharmacodynamic properties.
Wang YY; Yang YX; Zhe H; He ZX; Zhou SF
Drug Des Devel Ther; 2014; 8():2075-88. PubMed ID: 25364233
[TBL] [Abstract][Full Text] [Related]
6. Identification of a new azoreductase driven prodrug from bardoxolone methyl and 5-aminosalicylate for the treatment of colitis in mice.
Qiao X; Gong Y; Mou Y; Zhang YH; Huang ZJ; Wen XD
Chin J Nat Med; 2021 Jul; 19(7):545-550. PubMed ID: 34247779
[TBL] [Abstract][Full Text] [Related]
7. Bardoxolone methyl inhibits the infection of rabies virus via Nrf2 pathway activation in vitro.
Chi YL; Xie Y; Liu SQ; Zhu WY
Virol J; 2023 Nov; 20(1):258. PubMed ID: 37950261
[TBL] [Abstract][Full Text] [Related]
8. CDDO-Me Attenuates Vasogenic Edema and Astroglial Death by Regulating NF-κB p65 Phosphorylations and Nrf2 Expression Following Status Epilepticus.
Kim MJ; Park H; Choi SH; Kong MJ; Kim JE; Kang TC
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31574956
[TBL] [Abstract][Full Text] [Related]
9. Bardoxolone methyl induces apoptosis and autophagy and inhibits epithelial-to-mesenchymal transition and stemness in esophageal squamous cancer cells.
Wang YY; Yang YX; Zhao R; Pan ST; Zhe H; He ZX; Duan W; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():993-1026. PubMed ID: 25733817
[TBL] [Abstract][Full Text] [Related]
10. The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity.
Casares L; Moreno R; Ali KX; Higgins M; Dayalan Naidu S; Neill G; Cassin L; Kiib AE; Svenningsen EB; Minassi A; Honda T; Poulsen TB; Wiel C; Sayin VI; Dinkova-Kostova AT; Olagnier D; de la Vega L
Redox Biol; 2022 May; 51():102291. PubMed ID: 35313207
[TBL] [Abstract][Full Text] [Related]
11. Bardoxolone Methyl Suppresses Hepatitis B Virus Large Surface Protein Variant W4P-Related Carcinogenesis and Hepatocellular Carcinoma Cell Proliferation Via the Inhibition of Signal Transducer and Activator of Transcription 3 Signaling.
Gee MS; Kang SB; Kim N; Choi J; Kim NJ; Kim BJ; Inn KS; Lee JK
Pharmacology; 2018; 102(1-2):105-113. PubMed ID: 29953997
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure.
Tian C; Gao L; Zhang A; Hackfort BT; Zucker IH
J Pharmacol Exp Ther; 2019 Dec; 371(3):642-651. PubMed ID: 31601682
[TBL] [Abstract][Full Text] [Related]
13. Bardoxolone methyl modulates efflux transporter and detoxifying enzyme expression in cisplatin-induced kidney cell injury.
Atilano-Roque A; Aleksunes LM; Joy MS
Toxicol Lett; 2016 Sep; 259():52-59. PubMed ID: 27480280
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids.
Borella R; Forti L; Gibellini L; De Gaetano A; De Biasi S; Nasi M; Cossarizza A; Pinti M
Molecules; 2019 Nov; 24(22):. PubMed ID: 31766211
[TBL] [Abstract][Full Text] [Related]
15. The effect of ex vivo CDDO-Me activation on nuclear factor erythroid 2-related factor 2 pathway in white blood cells from patients with septic shock.
Noel S; Zheng L; Navas-Acien A; Fuchs RJ
Shock; 2014 Nov; 42(5):392-9. PubMed ID: 25105464
[TBL] [Abstract][Full Text] [Related]
16. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
[TBL] [Abstract][Full Text] [Related]
17. CDDO-Me, Sulforaphane and tBHQ attenuate the RANKL-induced osteoclast differentiation via activating the NRF2-mediated antioxidant response.
Xue P; Hu X; Powers J; Nay N; Chang E; Kwon J; Wong SW; Han L; Wu TH; Lee DJ; Tseng H; Ko CC
Biochem Biophys Res Commun; 2019 Apr; 511(3):637-643. PubMed ID: 30826055
[TBL] [Abstract][Full Text] [Related]
18. The Methyl Ester of 2-Cyano-3,12-Dioxooleana-1,9-Dien-28-Oic Acid Reduces Endometrial Lesions Development by Modulating the NFkB and Nrf2 Pathways.
Siracusa R; D'Amico R; Cordaro M; Peritore AF; Genovese T; Gugliandolo E; Crupi R; Impellizzeri D; Cuzzocrea S; Fusco R; Di Paola R
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33924360
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of C-28 methyl ester of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO-Me; bardoxolone methyl) on radiation-induced lung inflammation and fibrosis in mice.
Wang YY; Zhang CY; Ma YQ; He ZX; Zhe H; Zhou SF
Drug Des Devel Ther; 2015; 9():3163-78. PubMed ID: 26124639
[TBL] [Abstract][Full Text] [Related]
20. In vitro study on effect of bardoxolone methyl on cisplatin-induced cellular senescence in human proximal tubular cells.
Kurosaki Y; Imoto A; Kawakami F; Ouchi M; Morita A; Yokoba M; Takenaka T; Ichikawa T; Katagiri M; Nielsen R; Ishii N
Mol Cell Biochem; 2022 Mar; 477(3):689-699. PubMed ID: 34973124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
